| OMB APPROVAL | |
| OMB Number: Expires: |
3235-0060 March 31, 2009 |
| Estimated average burden hours per response …28.0 | |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported) | May 31, 2013 |
| APPLIED NANOTECH HOLDIINGS, INC. |
| (Exact name of registrant as specified in its charter) |
| TEXAS | 1-11602 | 76-0273345 |
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 3006 Longhorn Boulevard, Suite 107, Austin, Texas | 78758 |
| (Address of principal executive offices) | (Zip Code) |
| (512) 339 - 5020 |
| Registrant’s telephone number, including area code |
| (Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Effective May 31, 2013, Tracy Bramlett resigned as a member of the Board of Directors of the Company. Mr. Bramlett’s resignation is not in connection with any disagreement with the Company on any matter relating to our operations, policies, or practices. Mr. Bramlett was a member of the compensation committee and the nominating committee.
Item 9.01 – Financial Statements and Exhibits.
(c) Exhibits:
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Applied Nanotech Holdings, Inc. | |
| By: /s/ Douglas P. Baker | |
| Date: May 31, 2013 |
Douglas P. Baker Chief Financial Officer |